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Abstract. 
 
In most human and mouse antigen-present-
ing cells, the majority of intracellular major histocom-
patibility complex (MHC) class II molecules resides in 
late endocytic MHC class II compartments (MIICs), 
thought to function in antigen processing and peptide 
loading. However, in mouse A20 B cells, early en-
docytic class II-containing vesicles (CIIVs) have been 
reported to contain most of the intracellular MHC class 
II molecules and have also been implicated in forma-
tion of MHC class II–peptide complexes. To address 
this discrepancy, we have studied in great detail the en-
docytic pathways of both a human (6H5.DM) and a 
mouse (A20.A
 
b
 
) B cell line. Using quantitative immu-
noelectron microscopy on cryosections of cells that had 
been pulse–chased with transferrin-HRP or BSA-gold 
as endocytic tracers, we have identified up to six en-
docytic subcompartments including an early MIIC type 
enriched in invariant chain, suggesting that it serves as 
an important entrance to the endocytic pathway for 
newly synthesized MHC class II/invariant chain com-
plexes. In addition, early MIICs represented the earli-
est endocytic compartment containing MHC class II–
peptide complexes, as shown by using an antibody 
against an abundant endogenous class II–peptide com-
plex. The early MIIC exhibited several though not all of 
the characteristics reported for the CIIV and was situ-
ated just downstream of early endosomes. We have not 
encountered any special class II-containing endocytic 
structures besides those normally present in nonanti-
gen-presenting cells. Our results therefore suggest that 
B cells use conventional endocytic compartments 
rather than having developed a unique compartment to 
accomplish MHC class II presentation.
 
M
 
ajor
 
 histocompatibility complex (MHC)
 
1
 
 class II
molecules expressed at the surface of antigen-
presenting cells (APCs) such as B lymphocytes,
dendritic cells, and macrophages present bound peptides
derived from exogenous antigens to CD4-positive T lym-
phocytes. The antigens are internalized by fluid-phase-
and receptor-mediated endocytosis or by phagocytosis and
are proteolytically cleaved in endocytic compartments to
reveal small fragments that can associate with the binding
groove of MHC class II molecules (for reviews see 9, 14,
62). Peptide binding occurs predominantly to newly syn-
thesized rather than to surface-derived class II molecules
(3, 10, 34). Delivery of class II molecules from the biosyn-
thetic to the endocytic pathway requires their association
with invariant chain (I-chain; 9, 56). Class II/I–chain com-
plexes are thought to be transported from the TGN to late
endocytic compartments (10, 32, 34, 36, 37, 60) or (in addi-
tion) to earlier endosomes either directly or via the plasma
membrane (6, 8, 26, 48, 58). Upon arrival in endosomes,
the I-chain is rapidly degraded starting from the luminal
COOH terminus (47). A portion of the I-chain, CLIP
(class II-associated I-chain peptides) remains transiently
bound in the class II groove until it is exchanged for anti-
genic peptide, a process that is facilitated by the class II-
related molecule human leukocyte antigen (HLA)-DM
(H2-M in mice; 11, 45). It is not precisely known at which
site(s) in the endocytic pathway peptide binding takes
place. Peptide-loaded class II molecules are transported to
the plasma membrane via largely unknown pathways (59),
one of which is by exocytosis of MHC class II-enriched
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1. 
 
Abbreviations used in this paper
 
: APC, antigen-presenting cell; CD, cat-
ion dependent; CIIV, class II-containing vesicle; EE, early endosome;
HLA, human leukocyte antigen; I-chain, invariant chain; IEM, immuno-
electron microscopy; LAMPS, lysosome-associated membrane proteins;
MPR, mannose 6-phosphate receptor; LE, late endosome; MHC, major
histocompatibility complex; MIIC, MHC class II-enriched compartment;
Tf, transferrin.
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compartments (MIICs; 43, 64). Thus, there is abundant ev-
idence for the crucial role of the endocytic pathway in
class II antigen presentation.
At steady state, APCs harbor a major pool of their in-
tracellular class II molecules in endocytic compartments,
morphologically reminiscent of multivesicular late endo-
somes and lysosomes and which are collectively called MIICs
(20, 34, 35, 37). Recently, several subtypes of MIICs have
morphologically been distinguished, including those con-
taining internal vesicles and membrane sheets, termed mul-
tivesicular and multilaminar MIICs, respectively (38). In a
recent study on human B cells, an MIIC subtype was iden-
tified containing abundant I-chain and only a few vesicles.
This so-called early MIIC was proposed to be a precursor
compartment of the classical MIICs (17). Cell fractionation
and immunoelectron microscopy (IEM) suggested that these
early MIICs represent the main entry site of newly synthe-
sized class II molecules into the endocytic pathway (17,
38). These results were broadly consistent with those of
Castellino and Germain (6), who showed that class II/I–
chain complexes enter early endocytic compartments. Ex-
periments with exogenous tracers have shown that multi-
vesicular MIICs are positioned earlier in the endocytic
pathway than multilaminar MIICs and gradually mature
into the latter type (24). It is not yet clear how MIICs re-
late to classical endocytic compartments present in non-
APCs and whether APCs have developed special en-
docytic structures dedicated to class II functioning besides
other endosomes (53, 65). A detailed morphological de-
scription of the entire endocytic pathway in an APC and
the distribution of class II herein could help answer these
questions.
In non-APCs, at least four types of endocytic structures
have been distinguished on the basis of endocytic kinetics
and differential distribution of marker proteins, i.e., pri-
mary endocytic vesicles, early endosomes (EEs), late en-
dosomes (LEs), and lysosomes (for review see 29). How-
ever, due to the plasticity of the endocytic system, no clear
separation between EEs, LEs, and lysosomes can be made.
Nevertheless, several markers have proven to be useful to
make operational distinctions. Thus, the presence of the
transferrin (Tf) receptor and internalized Tf is commonly
used to identify EEs, while the cation-independent and
-dependent (CD) mannose-6-phosphate receptors (MPRs),
involved in the delivery of newly synthesized lysosomal
enzymes to the endocytic pathways, are widely used as dis-
criminative markers present in LEs but absent from lyso-
somes (16, 19, 25). Lysosomes can also be recognized by
the presence of lysosomal enzymes and lysosome-associ-
ated membrane proteins (LAMPS; for review see 21).
However, many cell types show hardly any MPRs in en-
docytic structures by IEM, while LAMPS and lysosomal
enzymes are present in typical dense lysosomes as well as
in LEs (16, 25). Both with IEM and cell fractionation, MIICs
do not contain significant amounts of TfRs but are en-
riched in lysosomal enzymes and LAMPs and therefore
are categorized as late endocytic or (pre)lysosomal struc-
tures (37, 41, 57, 60).
In B cells and macrophages, MIICs have been suggested
to represent peptide-loading compartments (20, 31, 41, 51,
60, 65). In accordance with this function, MIICs contain
high levels of HLA-DM molecules (35, 39, 52). However,
 
several other studies have shown that class II molecules
can already acquire peptide in early endocytic structures
(6, 13, 18). Using free-flow electrophoresis of mouse A20
B lymphoma cells, Amigorena and coworkers (1, 2) and
Pierre et al. (39) have described a distinct class II peptide-
loading compartment named class II-containing vesicle
(CIIV), which was thought to be different from classical
endosomes. The relation between CIIVs and MIICs is not
yet clear. The present study presents a detailed IEM char-
acterization of the endocytic pathways in a human B cell
line and in the murine A20 cells and addresses the ques-
tion of whether these APCs contain specialized and/or con-
ventional class II-containing endocytic compartments. Using
quantitative immunogold labeling and a recently improved
cryosectioning technique (28), we studied the progression
of internalized tracers through the endocytic pathway and
subdivided the endocytic pathway into up to six subcom-
partments. Class II molecules distributed to all types of en-
docytic compartments downstream of the main Tf-con-
taining EEs in both human and mouse B cells. Using an
antibody selectively recognizing an abundant class II–pep-
tide complex (43, 50), we found that early MIICs seen just
downstream of EEs represent the earliest endocytic struc-
tures exhibiting class II–peptide complexes. Our observa-
tions do not support the existence of a distinct set of en-
docytic organelles specialized in class II functioning.
 
Materials and Methods
 
Cells
 
The human 6H5.DM cell line was obtained by transfection of the human
B-LCL cell line Sweig with I-A
 
b
 
 
 
a
 
 and 
 
b
 
 genes and HLA-DM genes as de-
scribed before (43). The mouse lymphoblastoid cell line A20 was trans-
fected with the expression constructs containing cDNA encoding I-A
 
b
 
a
 
- and 
 
b
 
-chains driven by the human 
 
b
 
 actin promotor and neomycin- and
hygromycin-resistance genes. The expression constructs were identical to
those used to obtain 6H5.DM cells. 48 h after electroporation, the cells
were subjected to selection in culture medium containing 3 mg/ml G418
(GIBCO BRL, Gaithersburg, MD) and 1.2 mg/ml hygromycin B (Boeh-
ringer Mannheim, Indianapolis, IN). Stable transfectants (A20.A
 
b
 
) were
cloned by limiting dilution and screening for surface expression of I-A
 
b
 
molecules by flow cytometry using mAb Y3P (12). Both cell lines were
maintained in RPMI 1640 supplemented with 5% FCS, 200 mM 
 
l
 
-glutamine,
100 U/ml penicillin and streptomycin, 10 mM Hepes, 1 mM sodium pyru-
vate, and 5 
 
3
 
 10
 
2
 
5
 
 M 
 
b
 
-mercaptoethanol (all from GIBCO BRL) in 5%
CO
 
2
 
 atmosphere at 37
 
8
 
C (sRPMI).
 
Immunoelectron Microscopy
 
Cells were prepared for ultrathin cryosectioning and immunogold labeled
as described (15, 54). Briefly, cells were fixed in 2% paraformaldehyde
and washed in PBS and PBS/0.02 M glycine. Cell pellets were embedded
in 7.5% gelatin, which was solidified on ice and cut into small blocks. Af-
ter infiltration with 2.3 M sucrose for 3 h at 4
 
8
 
C, the blocks were mounted
and frozen in liquid nitrogen. Ultrathin cryosections were embedded in a
mixture of sucrose and methyl cellulose according to a novel procedure al-
lowing a better visualization of membranes (28). Ultrathin cryosections
were single immunolabeled with 10-nm gold particles or double immuno-
labeled with 5- and 10-nm or 10- and 15-nm protein A–gold particles.
 
Antibodies
 
For IEM we used rabbit polyclonal antisera specific for human HLA-DR
 
a
 
-chain (34), human I-chain NH
 
2 
 
and COOH terminus (11), human HLA-
DM
 
a
 
 (FS2; 52), human LAMP-1 (61), human CD-MPR (MSC1; kind gift
of Dr. K. von Figura, Georg-August University, Göttingen, Germany; 25),
mouse H-2Mb (K553 in biotinylated form; kind gift of Dr. L. Karlsson,
Johnson Pharmaceutical Research Institute, Scripps Research Institute, 
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La Jolla, CA,), mouse LAMP-1 (7), HRP (p7899; Sigma Chemical Co, St.
Louis, MO), mouse I-chain luminal part (S22; kind gift of Dr. N. Koch,
University of Bonn, Bonn, Germany; 27), and biotin (Rockland, Gilberts-
ville, PA). In addition, we used a rat mAb specific for the cytoplasmic tail
of mouse I-chain (In-1; 26), mouse mAbs specific for mouse cathepsin D
(generous gift of Dr. K. von Figura), I-A
 
b/d
 
/I-E (4), and for E
 
a
 
(DR
 
a
 
)52-
68 peptide bound to I-A
 
b
 
 called YA
 
e
 
 (12).
 
Internalization of Tf-HRP and BSA-Gold
 
Tf was coupled to HRP as described (55). Tf-HRP was added to 6H5.DM
or A20.A
 
b
 
 cells at a concentration of 25 
 
m
 
g/ml for 3 or 10 min at 37
 
8
 
C. The
cells were washed in cold medium and fixed as described above. BSA con-
jugated to 5-nm colloidal gold particles (54) was used in pulse–chase ex-
periments to label endocytic compartments. Cells were either incubated
with BSA-gold for 3 or 10 min at 37
 
8
 
C, washed extensively in cold me-
dium, and fixed (as described above), or incubated for 10 min at 37
 
8
 
C,
washed extensively, chased for 20 or 50 min at 37
 
8
 
C, and then fixed. Ul-
trathin cryosections of cells incubated with Tf-HRP, were immunolabeled
with anti-HRP antibody and 10-nm gold particles. Of both 3 and 10 min
time points, 20 cell profiles were randomly selected in the cryosections,
and gold particles were assigned to the various types of endocytic com-
partments (see Results and Tables I and II). For each compartment, the
percentage of the total immunogold was calculated. The same was done
with 5-nm BSA-gold particles internalized after 3- and 10-min pulse, and
10-min pulse plus 20- or 50-min chase. In the same sections, the contribu-
tion of each of the types of endocytic compartments to the total number of
endocytic compartments per cell profile was determined. In 6H5.DM and
A20.A
 
b
 
 cells six and five, respectively, different types of endocytic com-
partments were described morphologically and ordered according to their
position in the endocytic pathway (see Results). The distinctive morpho-
logical characteristics of each of these compartments were then used to
study the distribution of markers of interest. Of each immunolabeling, 20
cell profiles were evaluated quantitatively. Gold particles were assigned to
a compartment when lying within a distance of twice the particle size from
the membrane. Gold particles present on other, nonendocytic organelles
were not taken into account. Background labeling using an irrelevant anti-
body was negligible.
 
Results
 
Since no detailed morphological characterization of the
endocytic system in B lymphocytes has been described so
far, we have first analyzed the endocytic compartments in
the human B cell line 6H5.DM and the mouse B cell line
A20.A
 
b
 
. The A20 cell line has been used extensively in
biochemical fractionation studies (1, 2, 39) but has not been
studied morphologically in great detail. We have used Tf
conjugated to HRP as a receptor ligand or 5-nm BSA-gold
particles as fluid-phase endocytic tracer to study the pro-
gression of the internalized tracers through the endocytic
pathway in thawed cryosections of 6H5.DM and A20.A
 
b
 
cells. We took advantage of the improved cryosection mor-
phology (28), which enabled us to subdivide the endocytic
pathway into a series of compartments according to mor-
phological and endocytic characteristics. Next, we studied
the distribution of a variety of markers of the class II path-
way in these compartments by IEM.
 
Kinetics of Tracer Uptake in 6H5.DM Cells
 
Examination of ultrathin cryosections of 6H5.DM cells
pulsed with either Tf-HRP or with 5-nm BSA-gold particles
for 3 or 10 min, or pulsed for 10 min and chased for 20 or
50 min, revealed six types of endocytic compartments. Each
of the compartments displayed distinct morphological fea-
tures (Figs. 1 and 2; see also the schematic representation
of the various compartments in Fig. 3 and Table I). Fig. 1
shows several compartments in cells that had taken up
Tf-HRP (Fig. 1, 
 
A–D
 
) or BSA-gold (Fig. 1, 
 
E 
 
and 
 
F
 
).
Tf-HRP, detected by immunogold labeling, was found pri-
marily in small clathrin- and nonclathrin-coated vesicles
and tubules, which together were termed endocytic com-
partment type 1 (Fig. 1, 
 
A 
 
and 
 
B
 
; see numbering on the fig-
ures). Additional compartments displaying Tf-HRP showed
an extended straight or curved tubular morphology with
occasional internal vesicles (type 2; Fig. 1, 
 
C 
 
and 
 
D
 
) or
were typically irregularly shaped, with a few internal vesi-
cles (type 3; Fig. 1, 
 
B 
 
and 
 
D
 
). Type 2 and 3 compartments
could also easily be recognized by an electron-lucent area
inside the curvature of the compartment (Figs. 1, 
 
C 
 
and 2,
 
A 
 
and 
 
B
 
). Tf-HRP was not found in compartments other
than types 1–3. After 3 min of uptake, the majority of
BSA-gold particles was detected in types 1 and 2 (not
shown) and to some extent in type 3 compartments (Fig. 1
 
E
 
). Type 4, 5, and 6 compartments showed barely any
BSA-gold at 10 min (Fig. 1 
 
F
 
) but were reached by BSA-
gold after prolonged time periods of uptake (30–60 min,
not shown).
For a quantitative evaluation of endocytic tracers present
in each of the six morphologically distinguishable subcom-
partments, Tf-HRP immunogold labeling and BSA-gold
particles were counted in 20 random cell profiles at each
uptake time (Table I). After 3 min, 73% of the Tf-HRP
was detected in type 1, 22% in type 2, and 5% in type 3
compartments. The distribution of Tf-HRP was not signif-
icantly different after 10 min of uptake. This result indi-
cates that Tf-HRP is not transported much farther into the
endocytic pathway and marks the steady-state recycling
pathway of the Tf receptor. We conclude that type 1 and 2
compartments are the classical EEs in these cells.
Analysis of BSA-gold uptake revealed that immediately
after 3 and 10 min about one third of the total internalized
tracer was present in type 3 compartments. The labeling
further increased after 10 plus 20 min, with a simultaneous
decrease in types 1 and 2. This indicates that type 3 com-
partments were positioned downstream of types 1 and 2.
At 20 and 50 min chase, type 4, 5, and 6 compartments were
sequentially reached by BSA-gold, indicating that these com-
partments were situated in this order later in the endocytic
pathway. Type 4 compartments contained internal vesicles
reminiscent of classical multivesicular endosomes in most
cell types, type 6 displayed internal membrane sheets,
whereas type 5 had an intermediate morphology. Types 4,
5, and 6 did not contain detectable internalized Tf-HRP at
any time, which positioned them downstream of recycling
EEs. Type 4, 5, and 6 compartments represented MIICs
(see below) as defined originally (37) and together com-
prise the late endocytic compartments (Table I). Both
tracer kinetics and morphology indicated that type 3 com-
partments represent a transitional stage between the early
type 2 and the later type 4 compartments.
 
Quantitative Distribution of Class II, I-Chain,
HLA-DM, and YAe in 6H5.DM Cells
 
Human 6H5.DM cells displayed several useful features for
a study on class II distribution. First, they expressed I-A
 
b
 
molecules, which are able to bind peptide derived from the
endogenous DR 
 
a
 
-chain. These DR
 
a
 
52-68/I-A
 
b
 
 peptide
complexes are recognized by mAb YA
 
e
 
 (33), which can be 
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used in IEM. In addition, the high level of HLA-DM ex-
pression caused an increased number of peptide-loaded
class II molecules (42 and M.J. Kleijmeer, unpublished ob-
servations). Immunolabeling patterns for the various
markers of the class II pathway in 6H5.DM cells are illus-
trated in Figs. 1 and 2 and quantitatively represented in
Fig. 3 
 
A.
 
 Both HLA-DR and I-A
 
b
 
 molecules were most
prominently present in type 4, 5, and 6 compartments (il-
lustrated for DR in Fig. 2, 
 
A
 
, 
 
B
 
, and 
 
D
 
, and for I-A
 
b
 
 in Fig.
1 
 
F
 
) and to a much lower extent in type 3 (Fig. 2 
 
A
 
). As in
previous studies, types 4, 5, and 6 MIICs contained
LAMP-1, as shown for a type 6 multilaminar MIIC in Fig.
2 
 
A
 
, and were devoid of MPR (Fig. 2 
 
C
 
). DR and I-A
 
b
 
were undetectable in type 1 (Fig. 1 
 
A
 
) and type 2 compart-
ments and were present at low levels in type 3 compart-
ments. In contrast, labeling for both the NH
 
2
 
 and COOH
terminus of I-chain was low or undetectable in types 5 and
6 but was high in types 3 and 4 (Figs. 1, 
 
D 
 
and 
 
E 
 
and 2 
 
B
 
).
A low but significant amount was also detectable in type 2
compartments (Figs. 1 
 
C 
 
and 2 
 
B
 
). Almost 60% of the to-
tal COOH terminus labeling was contained in type 3 com-
partments. Type 3 compartments showed all of the charac-
teristics of early MIICs as defined previously (17), being
small, irregularly shaped multivesicular structures, often
showing an electron lucent area enclosed in the curvature
of the compartment. In type 4, NH
 
2
 
 terminus labeling was
about the same as in type 3, but COOH terminus labeling
was less than half of that in type 3. This may reflect the
degradation of I-chain, which starts at the COOH termi-
nus. As has been observed before (35, 52), DM was
Figure 1. Endocytic com-
partments in 6H5.DM cells.
Cells were incubated with Tf-
HRP (Tf) for 3 or 10 min or
with 5 nm BSA-gold (BSAg)
for 3 or 10 min. Tf was de-
tected with an HRP antibody
(15- or 10-nm gold particles,
A, B, C, and D, respectively).
In addition, ultrathin cryo-
sections were immunola-
beled with antibodies specific
for HLA-DR (A), I-chain
NH2 terminus (C and D, IN)
and I-chain (E, IC), or I-Ab
(F). The distinct types of en-
docytic compartments are
numbered 1 through 6. Tf is
present in small vesicles and
tubules (A and B), whereas
10-nm immunogold particles
for DR are present only on
the plasma membrane (A,
PM). Type 2 compartments
containing Tf are shown in C
and D and characterized by
an elongated tubular mor-
phology with few internal
vesicles. The typical electron
lucent area can be seen in the
curvature of the tubule (C).
Type 3 compartments are
shown in B, D, E, and F, and
exhibit an irregular morphol-
ogy and an electron lucent
content with some internal
vesicles. The type 3 compart-
ment contains Tf labeling (C
and D) and also 5 nm BSAg
after 3 and 10 min of uptake
(E and F, respectively). IN
labeling is present on both
the type 2 (C) and type 3
compartment (D). Immuno-
labeling for the luminal
epitope of I-chain (IC) is
abundant on the type 3 com-
partment (E). Multivesicular type 4 and multilaminar type 6 compartments (F) are negative for 5 nm BSAg after 10 min of uptake.
Colocalization of I-Ab and BSAg is seen only in the type 3 compartment. Bar, 100 nm.Kleijmeer et al. MIICs Are Conventional Endocytic Compartments 643
strongly enriched in type 6 multilaminar MIICs (47%). Of
the total peptide-loaded I-Ab molecules (YAe), 11% was
present in type 3 whereas most YAe labeling was found in
type 5, the intermediate MIICs. YAe labeling was absent
from types 1 and 2. Thus, type 3/early MIICs were the ear-
liest endocytic compartments showing YAe epitope (Fig. 2
D) and therefore may represent the earliest loading com-
partment, situated just downstream of the major Tf-con-
taining EEs (types 1 and 2). Most of the YAe, however,
was found in later type 4, 5, and 6 compartments, which
also contained most of the HLA-DM and class II mole-
cules (Fig. 2 C).
Kinetics of Tracer Uptake in A20.Ab Cells
By morphology, A20.Ab cells showed endocytic compart-
ments very similar to those of 6H5.DM cells (Figs. 4 and
5). However, the typical multilaminar type 6 was not
prominently present, whereas the intermediate type 5 was
absent. In their place, a dense compartment with some in-
 
Table I. Quantitative Analysis of Tf-HRP and BSA-Gold 
Uptake in 6H5.DM Cells
6H5DM Type 1 Type 2 Type 3 Type 4 Type 5 Type 6
3 min 73 22 5 222
Tf-HRP
10 min 79 18 3 222
Tf-HRP
3 min 47 24 29 222
BSA-gold
10 min 35 32 33 222
BSA-gold
10 1 20 min 10 10 40 37 3 2
BSA-gold
10 1 50 min 2 2 7 49 31 9
BSA-gold
6H5.DM cells were incubated at 378C with Tf-HRP for 3 and 10 min or pulse–chased
with 5-nm BSA-gold particles for the indicated time periods. Tf-HRP was visualized
on ultrathin cryosections with an HRP antibody and 10-nm gold particles. For each in-
cubation, 20 cell profiles were randomly selected, and gold particles labeling Tf-HRP
were assigned to a compartment when within 20 nm of a membrane. Only BSA-gold
particles within the limiting membrane of a compartment were counted. Percentages
of gold particles present in each compartment are shown. Six types of endocytic com-
partments could be distinguished, each with a characteristic morphology, as shown in
the table. The highest percentage of Tf-HRP is present in type 1 compartments, both
after 3 and 10 min of incubation. Tf-HRP has not been detected in types 4, 5, and 6 to
a significant extent. The quantitation of BSA-gold particles present in each of the
compartments during the pulse–chase shows that at 3- and 10-min pulse only types 1,
2, and 3 are reached, whereas type 4, 5, and 6 compartments are sequentially reached
by this tracer after 20- and 50-min chase. Figure 2. Characterization of MIICs in 6H5.DM cells. Ultrathin
cryosections of 6H5.DM cells were immunolabeled with antibod-
ies specific for LAMP-1 (A), I-chain COOH terminus, (B), CD-
MPR (C), and peptide-loaded I-Ab (C and D, YAe). LAMP-1
(10-nm gold particles) is present on a multilaminar type 6 com-
partment (A), which also contains DR labeling (15-nm gold parti-
cles). In addition, both LAMP-1 and DR are found on a type 3
compartment, although to a smaller extent than on the type 6
compartment. I-chain COOH terminus labeling is restricted to
type 2, 3, and 4 compartments (B), whereas DR is present in the
multivesicular type 4 and more abundantly on the mixed type 5
compartment. Two typical type 6 compartments are shown in C;
one of them shows labeling with YAe (10-nm gold particles). CD-
MPR is absent from the type 6 compartments; labeling of CD-
MPR (15 nm) is restricted to small, dense vesicles. YAe labels
both on a type 3 and type 6 compartment (D). Bars, 100 nm.
ternal membranes was found, which we indicated as type
5/6 (Figs. 4 E and 5, A and B). As in 6H5.DM cells, Tf-
HRP was mainly found in types 1 and 2 and was absent
from the multivesicular type 4 (Fig. 4 C). Type 1, 2, and 3
compartments were reached by internalized BSA-gold
particles after 3 min of uptake (Fig. 4, A and B). Type 5/6
compartments were not reached by BSA-gold before 10
min of uptake but obtained BSA-gold only after 10-min
pulse and 20- or 50-min chase (not shown). As in 6H5.DM
cells, type 2 and 3 often showed characteristic electron lu-
cent areas (Figs. 4, C and D, and 5 C). Notably, A20.Ab
cells contained considerably fewer endocytic compartments
than 6H5.DM cells, i.e., 10 versus 20 per random cell pro-
file, respectively.
Table II shows results of the quantitative evaluation of
Tf-HRP and BSA-gold uptake in A20.Ab cells. The trans-
port kinetics of Tf-HRP and BSA-gold were remarkably
similar to those in 6H5.DM cells, with the exception that the
later types 5/6 were more rapidly reached by BSA-gold, in-
creasing from 10% immediately after 10-min pulse to 56%
at 50-min chase. As in 6H5.DM cells, BSA-gold reached
type 3 compartments immediately after 3 min of uptake
(16%) and had increased to 38% after 10 plus 20 min. These
data indicate that also in A20.Ab cells, types 1 through 5/6
were sequentially reached by BSA-gold and that types 1
and 2 represent EEs. Thus, as in the human cells, type 3
compartments displayed an intermediate position between
the early types 1, 2, and the later 4 and 5/6 compartments.
Quantitative Distribution of Class II, I-Chain, and
H-2M in A20.Ab Cells
Class II labeling was found in all types of endocytic com-
partments, except type 1. Fig. 3 B shows the quantitativeThe Journal of Cell Biology, Volume 139, 1997 644
immunogold labeling data for class II, H-2M, and I-chain.
More than 50% of the total I-chain labeling was found in
type 3 compartments (illustrated in Fig. 6). I-chain was
also present in type 2 (Fig. 4 B) and type 4 and to a much
lower extent in type 5/6 (not illustrated). Of the total H2-M
labeling only 2% was present in type 2 (Fig. 4 E), 7% in
type 3, almost 30% in type 4, and 60% in type 5/6. Mor-
phology, accessibility to exogenous tracers, and immunola-
beling characteristics of type 3 MIICs were similar to those
in 6H5.DM. YAe labeling was too low for demonstration
with IEM. LAMP-1 was mainly present in type 5/6 com-
partments, similar to cathepsin D (Fig. 5 B). The type 5/6
compartments probably correspond to the late endocytic
MIICs in human B lymphocytes (17, 37, 38). Some LAMP-1
was detected in type 3 (Fig. 5 C). Approximately 60% of the
cathepsin D-positive endocytic compartments contained
class II. MPR labeling was absent from any of the type 1
through 5/6 compartments and was primarily found in ad-
jacent small vesicles and tubules (Fig. 5 A).
In conclusion, both human and mouse B cells displayed
multiple types of class II-containing endocytic MIICs with
internal membranes, including the early type of MIIC.
Early MIICs are located just downstream of the major re-
cycling EEs, contain DM molecules and abundant I-chain,
and are the first endocytic compartments displaying class
II–peptide complexes as recognized by YAe antibody. In
both cell types we have not found any special class II-con-
taining endocytic compartment apparent from the classical
ones described above.
Discussion
This study expands on our previous work describing
MIICs in B lymphoblasts, dendritic cells, and macro-
phages (for review see 24). In all of these cell types we
have found late endocytic MIICs with similar morphologi-
cal and molecular characteristics containing most of the in-
tracellular class II molecules. However, over the years sev-
eral reports have shown the transient presence of class II
molecules in early endocytic compartments (1, 2, 6, 8, 13,
Figure 3. Quantitative analysis and graphical representation of
Class II, DM, YAe, I-chain COOH terminus (IC), and I-chain
NH2 terminus (IN) distribution in endocytic compartments of
6H5.DM (A) and A20.Ab ( B ) cells. Ultrathin cryosections of
6H5.DM cells were single immunolabeled for the indicated mole-
cules using 10-nm gold particles. For each immunolabeling, 20
cell profiles were randomly selected and gold particles were
counted directly in the microscope. (A) In 6H5.DM cells, six types
of endocytic compartments could be distinguished, and only these
were subjected to quantitation. These compartments were identi-
fied by their morphological characteristics, as shown in the bot-
tom of the figure. The percentages of gold particles present in
each compartment are summarized in the table. The total num-
ber of gold particles counted is shown in the last column of the ta-
ble. Percentages of labeling for DR, DM, and I-Ab (top graph)
and of YAe, I-chain COOH terminus, and I-chain NH2 terminus
(bottom graph) are shown on the y axes. The graphs show strong
enrichment of IC labeling in type 3 compartments, whereas label-
ing for DR, DM, and I-Ab is most abundant in types 5 and 6. IN
labeling in types 3 and 4 is almost similar, while YAe is detected
first in type 3 compartments and significantly enriched in the later
types 4 to 6 (B). Quantitative analysis of A20.Ab cells was per-
formed as described for 6H5.DM cells. I-chain NH2 terminus is
strongly enriched in type 3 compartments, and both class II and
DM are abundant in type 4 and 5/6 compartments.Kleijmeer et al. MIICs Are Conventional Endocytic Compartments 645
26, 48, 49, 58). The criteria used in the different studies to
define early endocytic compartments varied, and their mor-
phological identity was often not revealed. We have now
studied for the first time in great detail the endocytic path-
way of both mouse A20.Ab and human 6H5.DM B lympho-
blasts, using semi-quantitative IEM.
Based on morphology, molecular marker distribution,
and position in the endocytic pathway, six and five types
of endocytic compartments could be distinguished in the
6H5.DM and A20.Ab cells, respectively (Tables I and II;
Fig. 7). Pulse–chase endocytosis of Tf-HRP and BSA-gold
indicated the position of these compartments in the en-
docytic pathway. Type 1, 2, and 3 compartments were situ-
ated early in the endocytic pathway. Types 1 and 2 repre-
sented the major Tf-recycling compartments and therefore
most likely were classical EEs in these cells. Type 3 had
Table II. Quantitative Analysis of Tf-HRP and BSA-Gold 
Uptake in A20.Ab Cells
A20 Type 1 Type 2 Type 3 Type 4 Type 5/6
3 min 74 21 5 22
Tf-HRP
10 min 82 12 6 22
Tf-HRP
3 min 63 21 16 22
BSA-gold
10 min 55 21 6 8 10
BSA-gold
10 1 20 min 14 3 38 38 7
BSA-gold
10 1 50 min 6 2 10 27 56
BSA-gold
Experiments were performed as described in Table I. Only five types, compared to six
types in 6H5.DM cells, showed morphologically distinguishable endocytic compart-
ments in A20.Ab cells. The quantitation of gold particles for Tf-HRP in A20.Ab cells
shows the abundant presence of Tf-HRP in type 1 compartments and lower amounts
in types 2 and 3. After 3 min of BSA-gold uptake, the tracer is most prominently
present in type 1, to some extent in type 2 and 3, but not in type 4 and 5/6 compart-
ments. Already after 10 min of internalization, type 4 and 5/6 compartments contain
significant amounts of BSA-gold, and these BSA-gold numbers increase after 20- and
50-min chase.
Figure 5. Characterization of MIICs in A20.Ab cells. Ultrathin
cryosections of A20.Ab cells were double immunolabeled for
class II and CD-MPR (A), cathepsin D (B), or LAMP-1 (C). La-
beling for class II (5-nm gold particles) is present in type 4 and
type 5/6 compartments (A), whereas CD-MPR labeling (10-nm
gold particles) is detected only in small, dense vesicles (arrows).
In B, a type 5/6 compartment positive for both class II (5-nm gold
particles) and cathepsin D (10-nm gold particles) is shown. Label-
ing for LAMP-1 (10-nm gold particles) and class II (5-nm gold
particles) is demonstrated in two multivesicular type 4 compart-
ments (C). A type 3 compartment shown here contains some
class II labeling, and only little LAMP-1 labeling. M, mitochon-
drion. Bars, 100 nm.
Figure 4. Endocytic compartments in A20.Ab cells. A20.Ab cells
were incubated with 5-nm BSA-gold particles (BSAg) for 3 and
10 min (A, B, D, and E, respectively) or with Tf-HRP (Tf) for 10
min (C). After 3 min of BSA-gold uptake, particles are present in
the type 1 compartment (A), which includes coated vesicles and
some noncoated vesicles and tubules. BSA-gold is also present in
the type 2 compartment at this time point (B) but is absent from
the multivesicular type 4. In this picture, both types are immuno-
labeled for I-chain NH2 terminus. A type 3 compartment, shown
in A and D, exhibits BSA-gold both after 3 min and 10 plus 50
min of uptake. Class II is present in type 3 compartments (A and
D), which show the typical irregularly shaped morphology and
electron lucent content with few internal vesicles (D). Type 5/6
compartments (E), with a dense content and few internal mem-
branes, do not show BSA-gold after 10 min of uptake, while the
type 2 compartment is positive for BSA-gold. Labeling for H-2M
(DM, 10-nm gold particles) reveals little H-2M in the type 2,
whereas type 5/6 compartments are strongly labeled for H-2M.
Bars, 100 nm.The Journal of Cell Biology, Volume 139, 1997 646
the characteristics of a transitional compartment between
the types 1 and 2 and the later type 4 compartments. Abun-
dance of I-chain, the presence of some Tf-HRP, rapid ar-
rival of BSA-gold, irregular shape, and few internal vesi-
cles characterized type 3 as early MIIC (17). As in our
previous studies (for review see 24), most of the intracellu-
lar class II molecules were detected in type 4, 5, and 6 com-
partments, which represented LEs (type 4) and lysosomes
(types 5 and 6), because of their marker profiles and be-
cause they were reached by internalized BSA-gold in se-
quence and after types 1, 2, and 3. The morphology of the
multivesicular (type 4), intermediate (type 5), and multi-
laminar (type 6) as well as their late position in the en-
docytic pathway matched the characteristics of MIICs as
originally defined (37). Types 5, 5/6, and 6 are probably
classical dense lysosomes. We have not encountered any
class II-positive endocytic structure distinct from the types
above. Fig. 7 shows the possible functional connections be-
tween the various types of compartments and how the
type numbers may correlate with existing nomenclature.
The labeling patterns for I-chain and YAe suggest that
type 3/early MIICs are of particular interest with respect to
class II function. First, early MIICs contained 40 and 55%
of the I-chain labeling in the human and mouse cells, re-
spectively. In types 4, 5, and 6, I-chain labeling progres-
sively decreased, most likely due to progressive proteoly-
sis. The abundance of I-chain COOH terminus epitope in
early MIICs (17, 38, and this study) probably reflects both
class II-bound and -detached I-chain. The sequential
COOH- to NH2-terminal degradation of I-chain likely ac-
counts for the earlier disappearance of COOH terminus la-
beling than of NH2 terminus labeling. An attractive inter-
pretation of the I-chain labeling pattern is that early MIICs
represent an important entry point of class II/I-chain mole-
cules coming from the TGN. This would be in accordance
with our previous observations (17, 38) and with those of
Cresswell (8) and Castellino and Germain (6). However, in
both the 6H5.DM and A20.Ab cells a small but significant
fraction of I-chain was found in type 2 compartments. It is
therefore likely that class II/I-chain complexes can enter
the endocytic pathway even earlier, either directly from
the TGN or via the plasma membrane (48, 49, 58, 63). This
latter pathway is probably a minor one in human B cells,
since major amounts of biosynthetically labeled class II
molecules cotransport with pro-cathepsin D directly from
the TGN to endosomes within the same vesicular interme-
diates (17). The fact that we found only low class II and
abundant I-chain labeling in early MIICs is possibly due to
differences in specificities and immunolabeling efficiencies
of the antibodies used. In addition, epitopes recognized by
the polyclonal antibody against human class II a-chain may
partly be masked when associated with I-chain. Class II/I-
chain complexes present in type 2 EEs may therefore have
been underscored. Several recent subcellular fractionation
studies on B cells have shown direct transport of ab/I-
chain complexes from the TGN to late MIIC-like com-
partments (32, 41, 57, 60). Our present morphological ob-
servations are broadly consistent with those of Castellino
and Germain (6) who used a refractionation and density
shift protocol on murine splenic B cells and found that
most newly synthesized class II/I-chain complexes first en-
ter EEs and then migrate farther down the endocytic sys-
tem (see also 49). In their study, EEs were marked by la-
beling with HRP during 10 min of fluid phase endocytosis.
Figure 7. Comprehensive scheme of endocytic compartments
and class II trafficking in B cells. The proposed relation between
the different types of endocytic compartments (1–6) including early
and late MIICs as described in this study, and the classical termi-
nology of endosomes and lysosomes are indicated. From our
present morphological observations and the kinetic data in sev-
eral recent fractionation studies (see Discussion), the following
model of class II transport can be put forward. Class II/I-chain
complexes derived from the TGN are transported to early MIICs
and possibly to a minor extent to the plasma membrane and other
endocytic compartments (see arrows with different thicknesses radi-
ating from the TGN). After arrival in the endocytic pathway, class
II/I-chain complexes migrate farther down the endocytic route
(see arrows between types 1–6) together with endocytosed anti-
gens, meanwhile being exposed to increasing proteolytic activity.
This activity results in the removal of I-chain, a process probably
already starting in type 3/early MIICs and progressing in later
compartments. Once class II is freed from the I-chain peptide
CLIP, antigenic peptides can bind to the class II molecules, a pro-
cess catalyzed by HLA-DM. Peptide loading of class II com-
mences in early MIICs and proceeds in later compartments, pos-
sibly depending on the type of class II and antigen. Escape of
class II–peptide complexes from the degradative route for depo-
sition at the cell surface has been shown to occur by exocytosis of
MIICs by which the limiting membrane of MIICs is incorporated
in the plasma membrane. During this process the internal vesicles
of MIICs are externalized as exosomes (43). Other pathways of
class II/peptide transport to the cell surface may very well exist
but have not yet been identified.
Figure 6. Immunogold labeling of I-chain in early MIICs of
A20.Ab cells. A type 3/early MIIC with characteristic empty
space is shown containing internalized BSA-gold particles and la-
beling for I-chain COOH terminus. Bar, 200 nm.Kleijmeer et al. MIICs Are Conventional Endocytic Compartments 647
We have defined EEs by their Tf content after 3 min of re-
ceptor-mediated uptake. After 10 min of BSA-gold fluid
phase uptake, tracer had already accessed early MIICs sig-
nificantly (17, this study). It therefore seems likely that the
EE subcellular fraction in the study of Castellino and Ger-
main (6) included early MIICs. Mellman et al. (30) pro-
posed a model in which class II/I-chain complexes are first
transported to EEs for removal of I-chain, whereupon
class II molecules are included in CIIVs that are formed
from EEs by a distinct budding process.
A second important aspect of early MIICs is their possi-
ble involvement in peptide loading. Although the majority
of the DRa52-68/I-Ab complexes, recognized by the YAe
antibody, was found in type 4, 5, and 6 compartments (31),
we now demonstrate the presence of the YAe epitope al-
ready in early MIICs. Early MIICs contain lysosomal en-
zymes so that degradation of I-chain and of endocytosed
antigen may occur simultaneously here (17). Since early
MIICs also harbor HLA-DM molecules, important require-
ments for antigen processing and peptide loading of class
II molecules are met in this compartment. Appearance of
antigen-presenting capacity after antigen uptake and ac-
quisition of class II SDS stability, as indications of peptide
loading, have led to the notion that late MIICs are the pri-
mary sites of peptide loading in macrophages and B cell lines
(6, 21, 41, 60, 65). In human B lymphoblasts, West et al. (60)
detected peptide loading activity first in a compartment dis-
tinct from early (Tf1) and late (MPR1) endosomes and
with a morphology similar to MIICs. Recently it was shown
that in addition, EEs can be involved in peptide loading
(13, 18). Such an activity was dependent on the type of an-
tigen used and, more interestingly, varied between different
epitopes present in one particular antigen. According to
Castellino and Germain (6), SDS-stable complexes present
in EEs may also represent recycling class II–peptide com-
plexes (40, 44, 46). Our quantitative IEM shows that at
steady state a little more than 10% of an abundant endog-
enous class II–peptide complex is present in early MIICs
but is undetectable in EEs. However, most of the com-
plexes were found in late MIICs, which may have accumu-
lated there after traversing the endocytic pathway and/or
represent complexes formed de novo in later compart-
ments. We have not found YAe labeling in any other type
of vesicle, distinct from early and late MIICs, which argues
against the possible existence of a unique compartment
serving as the exclusive assembly site of class II–peptide
complexes.
Although the endocytic compartments of 6H5.DM and
A20.Ab cells were very similar in most of their characteris-
tics, several differences were noted. 6H5.DM cells con-
tained many multilaminar MIICs (type 6), while A20.Ab
cells were mostly devoid of this MIIC type as well as of the
intermediate MIICs (type 5). In their place, a dense MIIC
(type 5/6) with only few internal membranes was promi-
nently present. Thus, the multilaminar structure may not
be the most discriminative morphological feature of MIICs
in general. We have previously detected dense instead of
multilaminar MIICs in dendritic cells from skin and spleen
(22, 23). In 6H5.DM cells, 95% of the 4–6 types of en-
docytic structures contained class II molecules, in contrast
to 60% in A20.Ab cells. Furthermore, sections of 6H5.DM
cells showed twice as many profiles of endocytic or-
ganelles than A20.Ab cells. A20.Ab cells have been re-
ported to contain ,5% of their total class II molecules in-
tracellularly (1) versus up to 36% in human B cells (17).
Together these data illustrate that the A20.Ab cells exhibit
relatively poorly developed intracellular antigen process-
ing and binding organelles, a feature that may hold for
other mouse B cells as well (M.J. Kleijmeer, unpublished
observations).
A most puzzling question concerns the relationship be-
tween CIIVs in mouse A20 cells (30) and MIICs defined in
several human and mouse APCs (24). As far as we could
test by IEM, our A20.Ab did not contain a distinct struc-
ture with all the characteristics reported for CIIVs. Never-
theless, many CIIV features matched those of early MIICs.
Like CIIVs, early MIICs were not a major station in the
Tf-recycling pathway, were markedly distinct from LEs
and lysosomes, and contained peptide-loaded class II mol-
ecules. Furthermore, CIIV-enriched fractions were de-
scribed to contain multivesicular structures (1) reminis-
cent of type 3 and 4 compartments in the present study. In
addition, HLA-DM occurred only at relatively low levels
in both early MIICs (this study) and CIIVs (39). On the
other hand, while CIIVs were the predominant location of
intracellular class II molecules and appeared to serve as an
exclusive site for compact forms of class II (2), we found
only 25% of the intracellular class II molecules in early
MIICs of A20.Ab cells and most in the later MIICs. A pos-
sible explanation for this could be that we have used A20
cells transfected with I-Ab. Since the M5/114 antibody rec-
ognizes both I-Ab and I-Ad, overexpression of one may
have caused a shift to additional late endocytic compart-
ments in our study. In both 6H5.DM and A20.Ab cells the
most striking feature of early MIICs was the enrichment in
I-chain. This feature differs markedly from the low I-chain
content reported for CIIVs (1, 2). It should be noted, how-
ever, that this may partly be caused by the specificity of anti-
body MKD6 used by Amigorena et al. (1), which does not
efficiently recognize class II/I-chain complexes (5). Finally,
since CIIVs were isolated by free-flow electrophoresis, they
may represent a subset of early endocytic membranes that,
because of their charge, show a unique deflection pattern.
In conclusion, our present observations show a major
fraction of I-chain present in early MIICs, positioned just
downstream of EEs. Most of the class II and HLA-DM
molecules distribute to typical late endosomal/lysosomal
MIICs (Fig. 7). Thus, MIICs appear to represent a heter-
ogenous set of conventional late and lysosomal compart-
ments, identical to their counterparts in non-APCs. The
current, poorly defined connotations of EE, LE, and lyso-
some are insufficient to describe what we can distinguish
in the endocytic pathway of class II by IEM. Since under-
standing of these compartments and the relationships be-
tween them is still incomplete, the term MIIC continues to
be a convenient designation. We propose that APCs em-
ploy their full endocytic system for antigen processing and
loading, which would enable them to process both easily
degradable and proteolytically resistant antigens into pep-
tides shortly or late after antigen uptake.
We would like to thank Dr. G. Raposo for helpful discussions, and R. Scri-
wanek is gratefully acknowledged for his excellent photographical work.
 This work was supported by the Dutch Organization of Scientific Re-
search (NWO) grant 901-09-241.The Journal of Cell Biology, Volume 139, 1997 648
Received for publication 17 February 1997 and in revised form 22 August
1997.
References
1. Amigorena, S., J.R. Drake, P. Webster, and I. Mellman. 1994. Transient ac-
cumulation of new class II MHC molecules in a novel endocytic compart-
ment in B lymphocytes. Nature (Lond.). 369:113–120.
2. Amigorena, S., P. Webster, J. Drake, J. Newcomb, P. Cresswell, and I.
Mellman. 1995. Invariant chain cleavage and peptide-loading in major
histocompatibility complex class II vesicles. J. Exp. Med. 181:1729–1741.
3. Bénaroche, P., M. Yilla, G. Raposo, K. Ito, K. Miwa, H.J. Geuze, and H.L.
Ploegh. 1995. How MHC class II molecules reach the endocytic pathway.
EMBO (Eur. Mol. Biol. Organ.) J. 14:37–49.
4. Bhattacharya, A., M.E. Dorf, and T.A. Springer. 1981. A shared alloanti-
genic determinant on Ia antigens encoded by the I-A and I-E subregions:
evidence for I region gene duplication. J. Immunol. 127:2488–2495.
5. Bikoff, E.K., R.N. Germain, and E.J. Robertson. 1995. Allelic differences
affecting invariant chain dependency of MHC class II subunit assembly.
Immunity. 2:301–310.
6. Castellino, F., and R.N. Germain. 1995. Extensive trafficking of MHC class
II-invariant chain complexes in the endocytic pathway and appearance of
peptide-loaded class II in multiple endocytic compartments. Immunity. 2:
73–88.
7. Chen, J.W., T.L. Murphy, M.C. Willingham, J.T. Pastan, and J.T. August.
1985. Identification of two lysosomal membrane glycoproteins. J. Cell
Biol. 101:85–95.
8. Cresswell, P. 1985. Intracellular class II HLA antigens are accessible to
transferrin-neuraminidase conjugates internalized by receptor-mediated
endocytosis. Proc. Natl. Acad. Sci. USA. 82:8188–8192.
9. Cresswell, P. 1994. Assembly, transport, and function of MHC class II mol-
ecules. Annu. Rev. Immunol. 12:259–293.
10. Davidson, H.W., and C. Watts. 1989. Epitope-directed processing of spe-
cific antigens by B-lymphocytes. J. Cell Biol. 109:85–92.
11. Denzin, L.K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation
from MHC class II ab dimers and facilitates peptide-loading. Cell. 82:
155–165.
12. Eastman, S., M. Deftos, P. de Roos, D.H. Hsu, L. Teyton, N.S. Braunstein,
C.J. Hackett, and A.Y. Rudensky. 1996. A study of the assembly of in-
variant chain peptide: MHC class II complexes using a new complex-spe-
cific monoclonal antibody. Eur. J. Immunol. 26:385–393.
13. Escola, J.-M., J.-C. Grivel, P. Chavrier, and J.-P. Gorvel. 1995. Different
endocytic compartments are involved in the tight association of class II
molecules with processed hen egg lysozyme and ribsnuclease A in B-cells.
J. Cell Sci. 108:2337–2345.
14. Germain, R.N., and D.H. Margulies. 1993. The biochemistry and cell biol-
ogy of antigen processing and presentation. Annu. Rev. Immunol. 11:
403–450.
15. Geuze, H.J., J.W. Slot, P.A. van der Ley, and R.C.T. Scheffer. 1981. Use of
colloidal gold particles in double-labeling immunoelectron microscopy of
ultrathin frozen tissue sections. J. Cell Biol. 89:653–665.
16. Geuze, H.J., W. Stoorvogel, G.J. Strous, J.E. Bleekemolen, and I. Mell-
man. 1988. Sorting of mannose 6-phosphate receptors and lysosomal
membrane proteins in endocytic vesicles. J. Cell Biol. 107:2491–2501.
17. Glickman, J.N., P.A. Morton, J.W. Slot, S. Kornfeld, and H.J. Geuze. 1996.
The biogenesis of the MHC class II compartment in human I-cell disease
B-lymphoblasts. J. Cell Biol. 132:769–785.
18. Griffin, J.P., R. Chu, and C.V. Harding. 1997. Early endosomes and late en-
docytic compartments generate different peptide/class II MHC com-
plexes via distinct processing mechanisms. J. Immunol. 158:1523–1532.
19. Griffiths, G., B. Hoflack, K. Simons, I. Mellman, and S. Kornfeld. 1988.
The mannose 6-phosphate receptor and the biogenesis of lysosomes.
Cell. 53:329–341.
20. Harding, C.V., and H.J. Geuze. 1993. Immunogenic peptides bind to class
II compartments in an early lysosomal compartment. J. Immunol. 151:
3988–3998.
21. Hunziker, W., and H.J. Geuze. 1996. Intracellular trafficking of lysosomal
membrane proteins. Bioessays. 18:379–389.
22. Kleijmeer, M.J., V.M.J. Oorschot, and H.J. Geuze. 1994. Human resident
Langerhans cells display a lysosomal compartment enriched in MHC
class II. J. Investig. Dermatol. 103:516–523.
23. Kleijmeer, M.J., M.A. Ossevoort, C.J.H. van Veen, J.J. van Hellemond, J.J.
Neefjes, W.M. Kast, C.J.M. Melief, and H.J. Geuze. 1995. MHC class II
compartments and the kinetics of antigen presentation in activated
mouse spleen dendritic cells. J. Immunol. 154:5715–5724.
24. Kleijmeer, M.J., G. Raposo, and H.J. Geuze. 1996. Characterization of
MHC class II compartments by immunoelectron microscopy. Methods.
10:191–207.
25. Klumperman, J., A. Hille, T. Veenendaal, V. Oorschot, W. Stoorvogel, K.
von Figura, and H.J. Geuze. 1993. Differences in the endosomal distribu-
tions of the two mannose 6-phosphate receptors. J. Cell Biol. 121:997–
1010.
26. Koch, N., S. Koch, and G.J. Hämmerling. 1982. Ia invariant chain detected
on lymphocyte surfaces by monoclonal antibody. Nature (Lond.). 299:
644–645.
27. Koch, S., A. Schultz and N. Koch. 1987. The production of recombinant
HLA-DRb and invariant chain polypeptides by cDNA expression in E.
coli. J. Immunol. Methods. 203:211–220.
28. Liou, W., H.J. Geuze, and J.W. Slot. 1996. Improved structural integrity of
cryosections for immunogold labeling. Histochem. Cell Biol. 106:41–58.
29. Mellman, I. 1996. Endocytosis and molecular sorting. Annu. Rev. Dev. Biol.
12:575–625.
30. Mellman, I., P. Pierre, and S. Amigorena. 1995. Lonely MHC molecules
seeking immunogenic peptides for meaningful relationships. Curr. Opin.
Cell Biol. 7:564–572.
31. Morkowski, S., G. Raposo, M.J. Kleijmeer, H.J. Geuze, and A.Y. Ruden-
sky. 1997. Assembly of an abundant endogenous MHC class II: peptide
complex in MHC class II compartments. Eur. J. Immunol. 27:609–617.
32. Morton, P.A., M.L. Zacheis, K.S. Giacoletto, J.A. Manning, and B.D.
Schwartz. 1995. Delivery of nascent MHC class II-invariant chain com-
plexes to lysosomal compartments and proteolysis of invariant chain by
cysteine proteases precedes peptide binding in B-lymphoblastoid cells. J.
Immunol. 154:137–150.
33. Murphy, D.B., D. Lo, S. Rath, R.L. Brinster, R.A. Flavell, A. Slanetz, and
C.A. Janeway, Jr. 1989. A novel MHC class II epitope expressed in thy-
mic medulla but not in cortex. Nature (Lond.). 338:765–767.
34. Neefjes, J.J., V. Stollorz, P.J. Peters, H.J. Geuze, and H.L. Ploegh. 1990.
The biosynthetic pathway of MHC class II but not class I molecules inter-
sects with the endocytic route. Cell. 61:171–183.
35. Nijman, H.W., M.J. Kleijmeer, M.A. Ossevoort, V.M.J. Oorschot, M.P.M.
Vierboom, M. van de Keur, P. Kenemans, W.M. Kast, H.J. Geuze, and
C.M.J. Melief. 1995. Antigen capture and MHC class II compartments of
freshly isolated and cultured human blood dendritic cells. J. Exp. Med.
182:163–174.
36. Odorizzi, C.G., I.S. Trowbridge, L. Xue, C.R. Hopkins, C.D. Davis, and
J.F. Collawn. 1994. Sorting signals in the MHC class II invariant chain cy-
toplasmic tail and transmembrane region determine trafficking to an en-
docytic processing compartment. J. Cell Biol. 126:317–330.
37. Peters, P.J., J.J. Neefjes, V. Oorschot, H.L. Ploegh, and H.J. Geuze. 1991.
Segregation of MHC class II molecules from MHC class I molecules in
the Golgi complex for transport to lysosomal compartments. Nature
(Lond.). 349:669–676.
38. Peters, P.J., G. Raposo, J.J. Neefjes, V. Oorschot, R.L. Leyendekker, H.J.
Geuze, and H.L. Ploegh. 1995. Major histocompatibility complex class II
compartments in human B-lymphoblastoid cells are distinct from early
endosomes. J. Exp. Med. 182:325–334.
39. Pierre, P., L.L. Denzin, C. Hammond, J.R. Drake, S. Amogorena, P. Cress-
well, and I. Mellman. 1996. HLA-DM is localized to conventional and
unconventional MHC class II-containing endocytic compartments. Im-
munity. 4:229–239.
40. Pinet, V., M. Vergelli, R. Martin, O. Bakke, and E.O. Long. 1995. Antigen
presentation mediated by recycling of surface HLA-DR molecules. Na-
ture (Lond.). 375:603–606.
41. Qiu, Y., X. Xu, A. Wandinger-Ness, D.P. Dalke, and S.K. Pierce. 1994.
Separation of subcellular compartments containing distinct functional
forms of MHC class II. J. Cell Biol. 125:595–605.
42. Ramachandra, L., S. Kovats, and A.Y. Rudensky. 1996. Variation in HLA-
DM expression influences conversion of MHC class II ab:class II-associ-
ated invariant chain peptide complexes to mature peptide-bound class II
ab dimers in a normal B-cell line. J. Immunol. 156:2196–2204.
43. Raposo, G., H.W. Nijman, W. Stoorvogel, R.L. Leyendekker, C.V. Hard-
ing, C.J.M. Melief, and H.J. Geuze. 1996. B lymphocytes secrete antigen
presenting vesicles. J. Exp. Med. 183:1–12.
44. Reid, P.A., and C. Watts. 1990. Cycling of cell-surface MHC glycoprotein
through primaquine-sensitive intracellular compartments. Nature (Lond.).
346:655–657.
45. Roche, P.A. 1995. HLA-DM: an in vivo facilitator of MHC class II peptide-
loading. Immunity. 3:259–262.
46. Roche, P.A., and P. Cresswell. 1990. Invariant chain association with HLA-DR
molecules inhibits immunogenic peptide binding. Nature (Lond.). 345:
615–618.
47. Roche, P.A., and P. Cresswell. 1991. Processing of the class II-associated
invariant chain generates a peptide binding site in intracellular HLA-DR
molecules. Proc. Natl. Acad. Sci. USA. 88:3150–3154.
48. Roche, P.A., C.L. Teletski, E. Stang, O. Bakke, and E.O. Long. 1993. Cell
surface HLA-DR-invariant chain complexes are targeted to endosomes
by rapid internalization. Proc. Natl. Acad. Sci. USA. 90:8581–9585.
49. Romagnoli, P., C. Layet, J. Yewdell, O. Bakke, and R.N. Germain. 1993.
Relationship between invariant chain expression and major histocompat-
ibility complex class II transport into early and late endocytic compart-
ments. J. Exp. Med. 177:583–596.
50. Rudensky, A.Y., P. Preston-Hurlburt, S.C. Hong, A. Barlow, and C.A. Jane-
way, Jr. 1991. Sequence analysis of peptides bound to MHC class II mole-
cules. Nature (Lond.). 353:622–628.
51. Rudensky, A.Y., M. Maric, E. Eastman, L. Shoemaker, P.C. de Roos, and
J.S. Blum. 1994. Intracellular assembly and transport of endogenous pep-
tide: MHC class II complexes. Immunity. 1:585–594.
52. Sanderson, F., M.J. Kleijmeer, A. Kelly, D. Verwoerd, A. Tulp, J.J.
Neefjes, H.J. Geuze, and J. Trowsdale. 1994. DM, an HLA-class II mole-Kleijmeer et al. MIICs Are Conventional Endocytic Compartments 649
cule with an accessory function in antigen presentation, accumulates in
an intracellular class II compartment. Science (Wash. DC). 266:1566–
1569.
53. Schmid, S.L., and M.R. Jackson. 1994. Making class II presentable. Nature
(Lond.). 369:103–104.
54. Slot, J.W., H.J. Geuze, and A.J. Weerkamp. 1988. Localization of macro-
molecular components by application of the immunogold technique on
cryosected bacteria. Methods Microbiol. 21:211–236.
55. Stoorvogel, W., H.J. Geuze, J.M. Griffith, A.L. Schwartz, and G.J. Strous.
1989. Relations between the intracellular pathways of the receptor for
transferin, asialoglycoprotein, and mannose 6-phosphate in human
hepatoma cells. J. Cell Biol. 108:2137–2142.
56. Teyton, L., D. O’Sullivan, P.W. Dickson, V. Lotteau, A. Sette, P. Fink, and
P.A. Peterson. 1990. Invariant chain distinguishes between the exoge-
nous and endogenous presentation pathways. Nature (Lond.). 348:39–44.
57. Tulp, A., D. Verwoerd, B. Dobberstein, H.L. Ploegh, and J. Pieters. 1994.
Isolation and characterization of the intracellular MHC class II compart-
ment. Nature (Lond.). 369:120–126.
58. Warmerdam, P.A.M., E. Long, and P.A. Roche. 1996. Isoforms of the in-
variant chain regulate transport of MHC class II molecules to antigen
processing compartments. J. Cell Biol. 133:281–291.
59. Watts, C. 1997. Capture and processing of exogenous antigens to presenta-
tion on MHC molecules. Annu. Rev. Immunol. 15:821–850.
60. West, M.A., J.M. Lucocq, and C. Watts. 1994. Antigen processsing and
class II MHC peptide-loading compartments in human B-lymphoblastoid
cells. Nature (Lond.). 369:147–151.
61. Williams, M.A., and M. Fukuda. 1990. Accumulation of lysosomal mem-
brane glycoproteins in lysosomes requires a tyrosine residue at a particu-
lar position in the cytoplasmic tail. J. Cell Biol. 111:955–966.
62. Wolf, P.R., and H.L. Ploegh, 1995. How MHC class II molecules acquire
peptide-cargo: biosynthesis and trafficking through the endocytic path-
way. Annu. Rev. Cell Dev. Biol. 11:267–306.
63. Wraight, C.J., P. van Endert, P. Moller, J. Lipp, N.R. Ling, I.C.M. MacLen-
nan, N. Koch, and G. Moldenhauer. 1990. Human major histocompatibil-
ity complex class II invariant chain is expressed on the cell surface. J.
Biol. Chem. 265:5787–5792.
64. Wubbolts, R., M. Fernandez-Borja, L. Oomen, D. Verwoerd, H. Janssen, J.
Calafat, A. Tulp, S. Dusseljee, and J.J. Neefjes. 1996. Direct vesicular
transport of MHC class II molecules from lysosomal structures to the cell
surface. J. Cell Biol. 135:611–622.
65. Xu, X., W. Song, H. Cho, Y. Qiu, and S.K. Pierce. 1995. Intracellular trans-
port of invariant chain-MHC class II complexes to the peptide-loading
compartment. J. Immunol. 155:2984–2992.